Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy

Published: March 1, 2024, 5:01 a.m.

Sponsored by Apellis Pharmaceuticals. John W. Kitchens, MD, invites Scott Walter, MD, and Esther Kim, MD, to discuss\xa0best practices for identifying appropriate patients with GA for treatment. Gain perspectives on patient selection, patient education, and safety considerations.